Dr. David Donald Buethe, MD

Dr. Buethe practices at HCA Florida Bayonet Point Hospital in Hudson, Florida, part of HCA Healthcare.

Dr. Buethe's NPI, 1013069186, was assigned on January 17, 2007. Dr. Buethe graduated from USF Health Morsani College of Medicine in 2006. Dr. Buethe holds Florida license ME110201.

Dr. Buethe's primary practice is HCA Florida Bayonet Point Hospital, at 14000 Fivay Rd, Hudson, FL 34667 in Pasco County. The practice phone is (727) 819-2929.

Dr. Buethe's primary practice is HCA Florida Bayonet Point Hospital in Hudson, Florida, part of HCA Healthcare. Dr. Buethe is also affiliated with HCA Florida Oak Hill Hospital. The medical group on file is Florida Urology Partners. Dmand AI also links Dr. Buethe to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buethe practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Buethe's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Buethe is board certified in urology by the American Board of Urology. Dmand AI has Dr. Buethe's licenses on file in 2 states: Florida and Oklahoma.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Buethe treats.

CMS data shows 2,086 Medicare services from Dr. Buethe across 25 procedure codes in 2024, for 589 Medicare patients. Medicare paid $140,125 for them.

CMS counts 589 Medicare patients who saw Dr. Buethe in 2024. The largest group is 75 to 84, with 256 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buethe's median patient age at 73, with 28% women.

In 2024, Dr. Buethe wrote 1,272 Medicare Part D claims for 414 patients. 88% of them were for generic drugs. CMS names the drug for 1,152 of them, across 21 drugs with 11 or more claims each, at $441,219 in total drug cost. In 2023, CMS named 1,108 claims across 20 drugs.

Dr. Buethe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buethe as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Buethe, published from 2008 to 2016. 2011 was the busiest year, with 6. The most frequent topics are Cations, Genetic Therapy and Gene Transfer Techniques. Dr. Buethe has published most often in Cancer Control. Dr. Buethe's most frequent co-authors are Wade J. Sexton, MD, Daniel J. Culkin, MD and Christopher M. Russell, MD.

CMS Open Payments shows 156 general payments to Dr. Buethe from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Axonics, Inc. paid the most, $1,128.

Dr. Buethe graduated from USF Health Morsani College of Medicine in 2006.

Dr. Buethe is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.